• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

NeuroVentures

edit

NeuroVentures is a specialty venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, medical devices and other therapeutics and technologies to treat Central Nervous System disorders. Founded in 2000, NeuroVentures is led by a team of experienced venture capital and life science professionals and advised by an internationally recognized network of medical and scientific thought leaders. NeuroVentures serves as the General Partner to the NeuroVentures Fund, LP, a Delaware limited partnership with committed capital in excess of $15 million.

Milestones

edit

• 
  NeuroVentures invested in Acumen Pharmaceuticals. (8/17/06)
  Posted 4/29/10 at 8:22pm
• 
  NeuroVentures invested in BrainCells. (3/1/08)
  Posted 5/22/09 at 10:38am via venturebeat.com

Investments

Videos

Sources

1. BrainCells raises $30M (venturebeat.com) [edit]
2. Cap Funding Report [edit]